Jefferies Financial Group Inc. Uro Gen Pharma Ltd. Transaction History
Jefferies Financial Group Inc.
- $20.1 Billion
- Q3 2025
A detailed history of Jefferies Financial Group Inc. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 2,199,652 shares of URGN stock, worth $53.5 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,199,652
Previous 2,199,652
-0.0%
Holding current value
$53.5 Million
Previous $30.1 Million
42.48%
% of portfolio
0.21%
Previous 0.27%
Shares
5 transactions
Others Institutions Holding URGN
# of Institutions
172Shares Held
43.9MCall Options Held
1.61MPut Options Held
433K-
Rtw Investments, LP New York, NY4.54MShares$111 Million1.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.22MShares$103 Million2.65% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$77.6 Million0.1% of portfolio
-
Morgan Stanley New York, NY2.53MShares$61.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$53.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $553M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...